Latest news with #PradhanMantriNationalDialysisProgramme
Time of India
10 hours ago
- Health
- Time of India
Safdarjung hospital starts DM in nephrology training from 2025 session
New Delhi: Vardhman Mahavir Medical College (VNMC) and Safdarjung Hospital have become Delhi's third institutions to start the Doctorate of Medicine (DM) in the nephrology training programme from the 2025 session. Previously, only AIIMS and RML Hospital offered this course. Dr Sandeep Bansal, the medical superintendent at Safdarjung Hospital, confirmed the allocation of three annual seats for DM in nephrology. "All three positions are being secured by candidates ranking within the top 10," he said. Principal of VNMC, Dr Geetika Khanna, expressed pride in launching this course. She emphasised the necessity of an additional workforce through postgraduate programmes, citing substantial patient numbers. Dr Himanshu Verma, who heads the nephrology department at Safdarjung Hospital, stated that approximately 6,000-7,000 kidney patients seek treatment at the hospital each month. India faces a significant shortage of nephrologists and dialysis specialists due to the increasing number of kidney-related health issues. Statistics indicate that 10% of Indians suffer from kidney-related conditions. The country has an expanding population of chronic kidney disease patients, with roughly 175,000 new end-stage renal disease cases annually. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Mundfalten reduzieren: Besser als 'Höhle der Löwen' Produkte Apotheken Gesundheit Mehr erfahren Undo The nation incurs significant expenses for dialysis and transplant treatments. The govt's Pradhan Mantri National Dialysis Programme assists financially challenged patients. Despite having excellent nephrologists and transplant surgeons, India requires more specialists to handle the increasing population of kidney patients, particularly considering the country's size. Qualified nephrologists are essential to reduce healthcare costs through early identification and prevention of kidney ailments.
New Indian Express
15-06-2025
- Health
- New Indian Express
Aadhaar now must for dialysis scheme benefits in Karnataka
BENGALURU: The state government has issued a notification mandating Aadhaar authentication for availing benefits under the Pradhan Mantri National Dialysis Programme (PMNDP), implemented through the Suvarna Arogya Suraksha Trust. This is to ensure better service delivery, transparency, and to ensure entitlements are distributed efficiently. According to the Department of Personnel and Administrative Reforms (DPAR), both Priority Household (PHH) and non-PHH ration card holders must either furnish proof of Aadhaar or undergo Aadhaar authentication to avail the benefits. However, the government clarified that no individual, adult or child will be denied treatment for lack of Aadhaar. In such cases, other identity documents will be accepted, and a register will be maintained to track these for audit and review purposes. Aadhaar enrolment facilities will be set up at block or taluk levels where centres are currently unavailable. In cases where biometric authentication fails, due to poor fingerprint quality or other issues, the department has recommended alternatives such as iris or face scans, OTP-based authentication, or physical Aadhaar letters validated through QR code scanners.
&w=3840&q=100)
Business Standard
11-06-2025
- Business
- Business Standard
Renalyx launches smart dialysis unit RxT21, plans ₹800 crore boost
Bengaluru-based Renalyx Health Systems has launched a cloud-enabled and AI-powered smart haemodialysis machine with real-time remote monitoring and clinical connectivity. Named RxT21 and priced at ₹6.7 lakh, the machine is claimed to be significantly cheaper than imported alternatives. Comparable models in the market cost 20–25 per cent more, the company said. Renalyx plans to invest ₹800 crore over the next four years to build manufacturing capacity for an initial 5,000 RxT21 machines by FY26, with an additional 1,500-unit capacity by FY28. The company will also manufacture consumables indigenously. Renalyx has manufacturing facilities in Bengaluru and Mysuru in Karnataka and in Mumbai, Maharashtra, to support its scale-up plans and meet rising demand. CDSCO approval for the RxT21 is in its final stages and expected by July 2025, while the USFDA approval process is under way and anticipated by March 2026, the company told Business Standard. Shyam Vasudeva Rao, founder and director of Renalyx Health Systems, said RxT21 would bring dialysis closer to patients' homes, helping reduce dropout rates. Remote monitoring is critical, especially as many rural patients miss their dialysis sessions—typically three per week—due to travel challenges. 'With this machine, we can monitor a patient's vitals during dialysis and stop the process immediately if any issue arises, reducing the need for highly trained manpower at rural centres,' Rao said. According to data from the Pradhan Mantri National Dialysis Programme (PMNDP), approximately 220,000 new cases of end-stage renal disease (ESRD) are reported in India annually, generating demand for 34 million dialysis sessions. Industry estimates suggest the country currently performs 21–22 million sessions annually, supported by 50,000 dialysis machines, 5,000 centres, and about 3,000 practising nephrologists. As the dialysis sector grows, domestic medical device makers are entering the fray. Currently, most dialysis machines in India are imported, with German firm Fresenius leading the market. Industry estimates indicate that 35,000 of the 50,000 machines deployed in India are from Fresenius. These machines typically cost between ₹7–8 lakh, excluding the cost of dialysers (the filtering unit) and other consumables. Founded in 2012, Renalyx also produces the RxT17 dialysis machine, which has standard features. It has licensed Bharat Electronics (BEL) to manufacture 6,000 RxT17 units over the next three years. The company has invested ₹52 crore so far in manufacturing and R&D. 'The company plans to raise funds through equity sales, supported by strong interest from Indian and international investors. In addition, it will raise debt, with promoters also infusing capital. Renalyx intends to go public within the next three years,' it said in a statement. Initial deployments of the RxT21 are planned in Maharashtra and Karnataka. Renalyx will then pursue rapid pan-India distribution of the machine in partnership with domestic collaborators and also export to global markets. The company has already secured orders from South Africa, the United States, and Europe.
Time of India
06-05-2025
- Health
- Time of India
Delhi Govt To Expand Dialysis Services With 150 New Machines At Six Hospitals
New Delhi: Delhi govt is set to expand its healthcare infrastructure by adding 150 new dialysis machines across six govt hospitals. This initiative will provide complimentary dialysis services to economically weaker sections whilst offering subsidised treatment to expansion is being executed through Pradhan Mantri National Dialysis Programme (PMNDP) and PPP Dialysis Project . This development supplements the existing network of 150 machines currently operating under these programmes at 10 govt hospitals."We are proud to lead this effort in Delhi to ensure that life-saving dialysis is not a privilege but a right for every citizen, especially the needy people," said health minister Pankaj Kumar Singh. "No patient should be denied care due to financial hardship."The minister further added, "This is not just a medical service expansion; it is a promise to our people that Delhi govt stands by their side during hardship."The current 150 dialysis machines are functioning at Bhagwan Mahavir Hospital, Guru Gobind Singh Govt Hospital, Indira Gandhi Hospital, Pt Madan Mohan Malaviya Hospital, Deep Chand Bandhu Hospital, Deen Dayal Upadhyay Hospital, Maharishi Valmiki Hospital, Lok Nayak Hospital, Rajiv Gandhi Super Speciality Hospital and Dr Hedgewar Aarogya new installations are occurring at six additional facilities—Dr Baba Saheb Ambedkar Hospital, Jag Pravesh Chandra Hospital, Burari Hospital, Janakpuri Super Specialty Hospital, Ambedkar Nagar Hospital, and Sanjay Gandhi Memorial PMNDP hospitals, patients possessing a National Food Security Card for PR & PRS category or an income certificate showing an annual income below Rs one lakh under the BPL category receive free dialysis PPP model hospitals, Delhi residents with three years of residency and holding either a National Food Security Card or an income certificate showing an annual income up to Rs 3,00,000 qualify for free dialysis.
